Related Experiment Video
Updated: Oct 30, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Immunological predictors of disease severity in patients with COVID-19
Asma Al Balushi1, Jalila AlShekaili2, Mahmood Al Kindi2
1Tropical and Infectious Diseases Unit, The Royal Liverpool University Hospital, Liverpool, UK; Internal Medicine Department, Suhar Hospital, Suhar, Oman.
Insights
Predictors of severe COVID-19 include elevated interleukin-6 (IL-6), inflammatory monocytes, and specific CD4 T cells. Identifying these immune markers aids in prioritizing critical care for COVID-19 patients.
Area of Science:
- Immunology
- Infectious Diseases
- Critical Care Medicine
Background:
- Understanding immune responses in COVID-19 is crucial for patient management.
- Identifying predictors of severe disease and poor outcomes is essential.
Purpose of the Study:
- To identify immunological predictors of poor outcomes in hospitalized COVID-19 patients.
- To differentiate immune cell profiles between hospitalized and non-hospitalized COVID-19 cases.
Main Methods:
- Prospective observational cohort study of 48 hospitalized and 53 non-hospitalized COVID-19 patients.
- Analysis of demographic data, comorbid conditions, and inflammatory markers.
- Multivariate regression analysis to identify independent predictors of intensive care unit (ICU) admission or death.
Main Results:
- Hospitalized patients were older and had more comorbidities, with significantly higher inflammatory markers (IL-6, CRP, ferritin, etc.).
- Higher levels of interleukin-6 (IL-6), frequency of large inflammatory monocytes (CD14+CD16+), and frequency of circulating naïve CD4+ T cells (CD27+CD28+CD45RA+CCR7+) were independent predictors of ICU admission or death.
Conclusions:
- Interleukin-6 (IL-6), inflammatory monocytes, and naïve CD4 T cells serve as independent immunological predictors of poor COVID-19 outcomes.
- These markers can guide prioritization for critical care and resource allocation in COVID-19 management.
Background:
Identifying the immune cells involved in coronavirus disease 2019 (COVID-19) disease progression and the predictors of poor outcomes is important to manage patients adequately.
Methods:
This prospective observational cohort study enrolled 48 patients with COVID-19 hospitalized in a tertiary hospital in Oman and 53 non-hospitalized patients with confirmed mild COVID-19.
Results:
Hospitalized patients were older (58 years vs 36 years, P < 0.001) and had more comorbid conditions such as diabetes (65% vs 21% P < 0.001). Hospitalized patients had significantly higher inflammatory markers (P < 0.001): C-reactive protein (114 vs 4 mg/l), interleukin 6 (IL-6) (33 vs 3.71 pg/ml), lactate dehydrogenase (417 vs 214 U/l), ferritin (760 vs 196 ng/ml), fibrinogen (6 vs 3 g/l), D-dimer (1.0 vs 0.3 μg/ml), disseminated intravascular coagulopathy score (2 vs 0), and neutrophil/lymphocyte ratio (4 vs 1.1) (P < 0.001). On multivariate regression analysis, statistically significant independent early predictors of intensive care unit admission or death were higher levels of IL-6 (odds ratio 1.03, P = 0.03), frequency of large inflammatory monocytes (CD14+CD16+) (odds ratio 1.117, P = 0.010), and frequency of circulating naïve CD4+ T cells (CD27+CD28+CD45RA+CCR7+) (odds ratio 0.476, P = 0.03).
Conclusion:
IL-6, the frequency of large inflammatory monocytes, and the frequency of circulating naïve CD4 T cells can be used as independent immunological predictors of poor outcomes in COVID-19 patients to prioritize critical care and resources.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

